Dr Steven Jeffrey Gottlieb, DO | |
1272 Virgil Langford Rd, Ste 202, Watkinsville, GA 30677 | |
(770) 953-3331 | |
(678) 744-0260 |
Full Name | Dr Steven Jeffrey Gottlieb |
---|---|
Gender | Male |
Speciality | Allergy/immunology |
Experience | 40 Years |
Location | 1272 Virgil Langford Rd, Watkinsville, Georgia |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023050143 | NPI | - | NPPES |
003261026A | Medicaid | GA | |
TL0595 | Medicaid | SC |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207KA0200X | Allergy & Immunology - Allergy | 0361 (South Carolina) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Atlanta Allergy And Asthma Pa | 1254372006 | 40 |
News Archive
Research results indicate that optical coherence tomography (OCT), a newly evolving imaging method, may be the best tool available to detect vulnerable plaque in coronary arteries. The findings will be presented at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF).
AMAG Pharmaceuticals, Inc. today announced that the Swiss Agency for Therapeutic Products (Swissmedic) has granted marketing authorization in Switzerland for ferumoxytol, an intravenous (IV) iron therapy to treat iron deficiency anemia (IDA) in adult patients with chronic kidney disease.
Measuring kidney function in children can be expensive, time-consuming for clinicians, and tedious for children, who may be exposed to radioactivity and subjected to a large number of blood draws.
Hemispherx Biopharma, Inc. today announced that, as result of court mediation proceedings, it has entered into a written agreement in principle with the Court-appointed lead plaintiffs to settle all of the currently pending securities class actions consolidated in the U.S. District Court for the Eastern District of Pennsylvania.
› Verified 4 days ago
Entity Name | Atlanta Allergy & Asthma Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1598796195 PECOS PAC ID: 1254372006 Enrollment ID: O20050523000011 |
News Archive
Research results indicate that optical coherence tomography (OCT), a newly evolving imaging method, may be the best tool available to detect vulnerable plaque in coronary arteries. The findings will be presented at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF).
AMAG Pharmaceuticals, Inc. today announced that the Swiss Agency for Therapeutic Products (Swissmedic) has granted marketing authorization in Switzerland for ferumoxytol, an intravenous (IV) iron therapy to treat iron deficiency anemia (IDA) in adult patients with chronic kidney disease.
Measuring kidney function in children can be expensive, time-consuming for clinicians, and tedious for children, who may be exposed to radioactivity and subjected to a large number of blood draws.
Hemispherx Biopharma, Inc. today announced that, as result of court mediation proceedings, it has entered into a written agreement in principle with the Court-appointed lead plaintiffs to settle all of the currently pending securities class actions consolidated in the U.S. District Court for the Eastern District of Pennsylvania.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Steven Jeffrey Gottlieb, DO 8200 Roberts Dr Ste 450, Sandy Springs, GA 30350-4115 Ph: (709) 528-6127 | Dr Steven Jeffrey Gottlieb, DO 1272 Virgil Langford Rd, Ste 202, Watkinsville, GA 30677 Ph: (770) 953-3331 |
News Archive
Research results indicate that optical coherence tomography (OCT), a newly evolving imaging method, may be the best tool available to detect vulnerable plaque in coronary arteries. The findings will be presented at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF).
AMAG Pharmaceuticals, Inc. today announced that the Swiss Agency for Therapeutic Products (Swissmedic) has granted marketing authorization in Switzerland for ferumoxytol, an intravenous (IV) iron therapy to treat iron deficiency anemia (IDA) in adult patients with chronic kidney disease.
Measuring kidney function in children can be expensive, time-consuming for clinicians, and tedious for children, who may be exposed to radioactivity and subjected to a large number of blood draws.
Hemispherx Biopharma, Inc. today announced that, as result of court mediation proceedings, it has entered into a written agreement in principle with the Court-appointed lead plaintiffs to settle all of the currently pending securities class actions consolidated in the U.S. District Court for the Eastern District of Pennsylvania.
› Verified 4 days ago